These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9245142)

  • 1. [The quality and efficacy of a Russian live mumps vaccine].
    Popov VF; Kaplunova OP; Iunasova TN
    Zh Mikrobiol Epidemiol Immunobiol; 1997; (2):51-3. PubMed ID: 9245142
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative study on the neurovirulence of different vaccine strains of parotitis virus in monkeys.
    Rozina EE; Hilgenfeldt M
    Acta Virol; 1985 May; 29(3):225-30. PubMed ID: 2864823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of live mumps virus vaccines.
    Furesz J
    J Med Virol; 2002 Jul; 67(3):299-300. PubMed ID: 12116018
    [No Abstract]   [Full Text] [Related]  

  • 4. [The specific activity and immunological safety of a live mumps vaccine from the Leningrad-3 strain in intranasally revaccinated adult subjects].
    Iuminova NV; Krasnova VP; Liashenko VA
    Vopr Virusol; 1994; 39(3):113-6. PubMed ID: 8091749
    [No Abstract]   [Full Text] [Related]  

  • 5. [The results and prospects for the vaccinal prophylaxis of mumps in Russia].
    Zotin VV; Val'kova IV
    Zh Mikrobiol Epidemiol Immunobiol; 1996; (4):61-4. PubMed ID: 9027180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection of mumps in children with various underlying diseases: application of a live attenuated mumps and trivalent measles-rubella-mumps (MRM) vaccines in these children.
    Kanesaki T; Baba K; Tsuda N; Yabuuchi H; Yamanishi K; Takahashi M
    Biken J; 1986 Dec; 29(3-4):63-71. PubMed ID: 3304276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current status of mumps and mumps vaccine in the United States.
    Hayden GF; Preblud SR; Orenstein WA; Conrad JL
    Pediatrics; 1978 Dec; 62(6):965-9. PubMed ID: 733425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of change in cell substrate on the critical quality attributes of L-Zagreb Mumps vaccine manufactured using parallel plate bioreactor.
    Muley R; Dhere R
    Biologicals; 2020 Sep; 67():29-37. PubMed ID: 32855039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and development of a promising novel mumps vaccine candidate strain.
    Liang Y; Ma S; Liu L; Zhao H; Wang L; Jiang L; Xie Z; Dong C; Li Q
    Microbes Infect; 2010 Dec; 12(14-15):1178-87. PubMed ID: 20800105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of vaccination of marrow transplant recipients with a live attenuated measles, mumps, and rubella vaccine.
    Ljungman P; Fridell E; Lönnqvist B; Bolme P; Böttiger M; Gahrton G; Linde A; Ringdén O; Wahren B
    J Infect Dis; 1989 Apr; 159(4):610-5. PubMed ID: 2647859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matched case-control study of effectiveness of live, attenuated S79 mumps virus vaccine against clinical mumps.
    Fu C; Liang J; Wang M
    Clin Vaccine Immunol; 2008 Sep; 15(9):1425-8. PubMed ID: 18667635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Testing for the safety, reactogenicity and antigenic properties of a live thermostable mumps vaccine made from the Leningrad-3 strain].
    Iuminova HV; Liashenko VA; Krasnova VP; Krivenkova VN; Goliazhenkova MIu; Unanov SS
    Vopr Virusol; 1991; 36(4):310-2. PubMed ID: 1796587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccinoprophylaxis of mumps using mumps vaccine, strain Sofia 6, in Bulgaria.
    Odisseev H; Gacheva N
    Vaccine; 1994 Nov; 12(14):1251-4. PubMed ID: 7856287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mumps vaccine L-Zagreb, prepared in chick fibroblasts. I. Production and field trials.
    Beck M; Welsz-Malecek R; Mesko-Prejac M; Radman V; Juzbasic M; Rajninger-Miholic M; Prislin-Musklic M; Dobrovsak-Sourek V; Smerdel S; Stainer DW
    J Biol Stand; 1989 Jan; 17(1):85-90. PubMed ID: 2646300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indications for measles-mumps-rubella vaccination in a child with prior thrombocytopenia purpura.
    Pool V; Chen R; Rhodes P
    Pediatr Infect Dis J; 1997 Apr; 16(4):423-4. PubMed ID: 9109153
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of a combined measles-mumps-rubella-chickenpox vaccine.
    Just M; Berger R; Just V
    Dev Biol Stand; 1986; 65():85-8. PubMed ID: 3030863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aseptic meningitis after vaccination against measles and mumps.
    Cizman M; Mozetic M; Radescek-Rakar R; Pleterski-Rigler D; Susec-Michieli M
    Pediatr Infect Dis J; 1989 May; 8(5):302-8. PubMed ID: 2726323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monkey neurovirulence test for live mumps vaccine.
    Maximova O; Dragunsky E; Taffs R; Snoy P; Cogan J; Marsden S; Levenbook I
    Biologicals; 1996 Sep; 24(3):223-4. PubMed ID: 8978921
    [No Abstract]   [Full Text] [Related]  

  • 19. Mumps vaccine virus strains and aseptic meningitis.
    Bonnet MC; Dutta A; Weinberger C; Plotkin SA
    Vaccine; 2006 Nov; 24(49-50):7037-45. PubMed ID: 16884835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on live attenuated mumps vaccine. II. Follow-up study on the efficacy of Biken Vaccine.
    Isomura S; Ozaki T; Morishima T; Nagayoshi S; An S
    Biken J; 1976 Sep; 19(3):115-8. PubMed ID: 1016214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.